SOX17 was verified to be a risk gene for PAH-CHD in PAH children with important factors of bone morphogenetic protein receptor type 2 (BMPR2), TBX4, and SOX17 (30). This evidence concerns the gene TBX4 and pulmonary arterial hypertension.